FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912086340> ?p ?o ?g. }

• W2912086340 endingPage "24" @default.
• W2912086340 startingPage "15" @default.
• W2912086340 abstract "Morin is a flavonoid has been reported with several pharmacological effects such as, antioxidant, anti-inflammatory, anticancer, antidiabetic, etc. However, morin has low solubility in water, which decreases the bioavailability and limits its clinical application. In this way, to improve the pharmaceutical properties, morin was complexed in hydroxypropyl-β-cyclodextrin (HP-β-CD) and its oral bioavailability and anti-inflammatory effects were evaluated. Initially, a phase solubility study was performed, which showed that HP-β-CD would be the better cyclodextrin for the formation of complexes with morin. The morin/HP-β-CD inclusion complex (1:1) was prepared by freeze-drying method. The sample obtained was characterized by DSC, FTIR, PXRD, SEM and 1H NMR techniques, evidencing the formation of morin/HP-β-CD inclusion complex. In addition, complexation efficiency (98.3%) and loading content (17.63%), determined by HPLC demonstrated that morin was efficiently complexed in HP-β-CD. In vitro dissolution study confirmed that morin/HP-β-CD inclusion complex increased the solubility and dissolution rate of morin. The oral bioavailability of the morin/HP-β-CD complex and free morin were evaluated through a pharmacokinetic study in rat plasma. The oral bioavailability of morin complexed with HP-β-CD was increased by 4.20 times compared with the free morin. Hyperalgesia induced by carrageenan and carrageenan-induced pleurisy were carried out in mice to evaluate the antihyperalgesic and anti-inflammatory activities of free morin and inclusion complex. Morin/HP-β-CD inclusion complex showed antihyperalgesic effect in inflammatory pain model and anti-inflammatory effect decreasing leukocyte migration and TNF-α levels at a lower dose than free morin. Therefore, the morin/HP-β-CD inclusion complex improved the solubility, dissolution rate, oral bioavailability, antihyperalgesic and anti-inflammatory effects of morin. In this way, the morin/HP-β-CD inclusion complex exhibits potential for development of new pharmaceutical product for future clinical applications." @default.
• W2912086340 created "2019-02-21" @default.
• W2912086340 creator A5007966689 @default.
• W2912086340 creator A5024352337 @default.
• W2912086340 creator A5026813880 @default.
• W2912086340 creator A5038913431 @default.
• W2912086340 creator A5042780905 @default.
• W2912086340 creator A5044417808 @default.
• W2912086340 creator A5046422006 @default.
• W2912086340 creator A5072894537 @default.
• W2912086340 creator A5073188396 @default.
• W2912086340 creator A5081571608 @default.
• W2912086340 creator A5081720413 @default.
• W2912086340 creator A5087888185 @default.
• W2912086340 creator A5089774111 @default.
• W2912086340 date "2019-04-01" @default.
• W2912086340 modified "2023-10-01" @default.
• W2912086340 title "Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects" @default.
• W2912086340 cites W1007853786 @default.
• W2912086340 cites W1662586196 @default.
• W2912086340 cites W1980255751 @default.
• W2912086340 cites W1990515270 @default.
• W2912086340 cites W1991785827 @default.
• W2912086340 cites W1992154295 @default.
• W2912086340 cites W1995801479 @default.
• W2912086340 cites W2000732921 @default.
• W2912086340 cites W2001570423 @default.
• W2912086340 cites W2001976307 @default.
• W2912086340 cites W2002148098 @default.
• W2912086340 cites W2009007666 @default.
• W2912086340 cites W2013731265 @default.
• W2912086340 cites W2013930062 @default.
• W2912086340 cites W2017227428 @default.
• W2912086340 cites W2025697847 @default.
• W2912086340 cites W2027637273 @default.
• W2912086340 cites W2034119127 @default.
• W2912086340 cites W2036663081 @default.
• W2912086340 cites W2041826135 @default.
• W2912086340 cites W2044932064 @default.
• W2912086340 cites W2049196544 @default.
• W2912086340 cites W2054800049 @default.
• W2912086340 cites W2062790180 @default.
• W2912086340 cites W2065432788 @default.
• W2912086340 cites W2070094522 @default.
• W2912086340 cites W2077223920 @default.
• W2912086340 cites W2085659241 @default.
• W2912086340 cites W2129039800 @default.
• W2912086340 cites W2171223432 @default.
• W2912086340 cites W2177576924 @default.
• W2912086340 cites W2194081718 @default.
• W2912086340 cites W2319737480 @default.
• W2912086340 cites W2515837249 @default.
• W2912086340 cites W2519414593 @default.
• W2912086340 cites W2536851286 @default.
• W2912086340 cites W2558335684 @default.
• W2912086340 cites W2590725766 @default.
• W2912086340 cites W2596207351 @default.
• W2912086340 cites W2602139165 @default.
• W2912086340 cites W2603132405 @default.
• W2912086340 cites W2605669332 @default.
• W2912086340 cites W2725168884 @default.
• W2912086340 cites W2733232649 @default.
• W2912086340 cites W2734441745 @default.
• W2912086340 cites W2767842869 @default.
• W2912086340 cites W2789529164 @default.
• W2912086340 cites W2790174680 @default.
• W2912086340 doi "https://doi.org/10.1016/j.fct.2019.01.038" @default.
• W2912086340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30738132" @default.
• W2912086340 hasPublicationYear "2019" @default.
• W2912086340 type Work @default.
• W2912086340 sameAs 2912086340 @default.
• W2912086340 citedByCount "42" @default.
• W2912086340 countsByYear W29120863402019 @default.
• W2912086340 countsByYear W29120863402020 @default.
• W2912086340 countsByYear W29120863402021 @default.
• W2912086340 countsByYear W29120863402022 @default.
• W2912086340 countsByYear W29120863402023 @default.
• W2912086340 crossrefType "journal-article" @default.
• W2912086340 hasAuthorship W2912086340A5007966689 @default.
• W2912086340 hasAuthorship W2912086340A5024352337 @default.
• W2912086340 hasAuthorship W2912086340A5026813880 @default.
• W2912086340 hasAuthorship W2912086340A5038913431 @default.
• W2912086340 hasAuthorship W2912086340A5042780905 @default.
• W2912086340 hasAuthorship W2912086340A5044417808 @default.
• W2912086340 hasAuthorship W2912086340A5046422006 @default.
• W2912086340 hasAuthorship W2912086340A5072894537 @default.
• W2912086340 hasAuthorship W2912086340A5073188396 @default.
• W2912086340 hasAuthorship W2912086340A5081571608 @default.
• W2912086340 hasAuthorship W2912086340A5081720413 @default.
• W2912086340 hasAuthorship W2912086340A5087888185 @default.
• W2912086340 hasAuthorship W2912086340A5089774111 @default.
• W2912086340 hasConcept C13965031 @default.
• W2912086340 hasConcept C142724271 @default.
• W2912086340 hasConcept C155574463 @default.
• W2912086340 hasConcept C178790620 @default.
• W2912086340 hasConcept C181389837 @default.
• W2912086340 hasConcept C185592680 @default.
• W2912086340 hasConcept C2778004101 @default.

• next